Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001140361-22-009945
Filing Date
2022-03-17
Accepted
2022-03-17 17:26:58
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-4 ny20003153x4_s4.htm S-4 5927451
2 EXHIBIT 23.3 ny20003153x4_ex23-3.htm EX-23.3 1775
3 EXHIBIT 23.4 ny20003153x4_ex23-4.htm EX-23.4 2110
4 EXHIBIT 23.5 ny20003153x4_ex23-5.htm EX-23.5 1918
5 EXHIBIT 99.1 ny20003153x4_ex99-1.htm EX-99.1 4176
6 FILING FEES TABLE ny20003153x4_ex107.htm EX-FILING FEES 15230
7 logo_centerviewpartnersv2.jpg GRAPHIC 20936
8 ny20003153x1_flowchart01.jpg GRAPHIC 74375
9 ny20003153x1_flowchart02.jpg GRAPHIC 108537
10 ny20003153x1_flowchart03.jpg GRAPHIC 117430
11 ny20003153x1_piechart01.jpg GRAPHIC 62309
12 ny20003153x1_piechart02.jpg GRAPHIC 47804
13 ny20003153x4_ex99-1image01.jpg GRAPHIC 17995
  Complete submission text file 0001140361-22-009945.txt   6571555
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: S-4 | Act: 33 | File No.: 333-263667 | Film No.: 22749982
SIC: 2835 In Vitro & In Vivo Diagnostic Substances